Today: 20 May 2026
Meta stock slips after Reality Labs cuts; investors turn to Jan. 28 earnings
14 January 2026
2 mins read

Meta stock slips after Reality Labs cuts; investors turn to Jan. 28 earnings

New York, Jan 14, 2026, 16:14 (EST) — Trading in after-hours

  • Shares of Meta Platforms dropped 2.5% during regular hours, dragged down by fresh Reality Labs budget cuts and a wider tech sell-off on Wall Street.
  • Meta scheduled its quarterly earnings for Jan. 28, a key moment to gauge spending discipline amid its AI infrastructure build-out.

Meta Platforms shares dropped roughly 2.5% on Wednesday, marking another turbulent session for the social media giant amid its move to scale down segments of its metaverse business. The stock ended the day at $615.38.

The cuts are crucial as Meta works to reassure investors while funneling cash into AI infrastructure, all while pledging to manage margins. Reality Labs has been a major spending driver, so even a slight signal of stricter cost control tends to move the stock sharply.

U.S. stocks dropped Wednesday, dragged down by tech and financial sectors. The Nasdaq slid 0.96%, while the S&P 500 slipped 0.53%, based on preliminary figures.

Meta is cutting roughly 10% of its Reality Labs division—the team behind its virtual and augmented reality gear—and will close several VR game studios in the process. Meta spokesperson Tracy Clayton told The Verge the company is pivoting investment “from the Metaverse toward Wearables,” with plans to funnel savings back into growing its wearables business. The Verge

Reality Labs has been the core of Meta’s efforts to expand beyond Facebook and Instagram, spanning from Quest headsets to software and gaming content. Shutting down studios could dry up the flow of new VR titles, even as Meta doubles down on smart glasses and other gadgets designed to lock users into its ecosystem.

Meta is pushing hard on scaling its AI computing power. CEO Mark Zuckerberg unveiled a new “Meta Compute” program this week to manage data centers and supplier deals. The company aims to crank out “tens of gigawatts this decade,” with even more down the line. Infrastructure head Santosh Janardhan and Daniel Gross will co-lead the effort, alongside Dina Powell McCormick, recently appointed president and vice chairman, Zuckerberg wrote. Reuters

Meta, alongside Microsoft, Alphabet, and Amazon, is battling for chips, power, and data-center space amid a fresh surge in generative AI-driven capital spending. This scramble has intensified investor scrutiny on capex—and its impact on free cash flow—even among firms with robust ad revenues.

Meta announced after the close that it plans to release its fourth-quarter and full-year 2025 earnings on Wednesday, Jan. 28, followed by a conference call at 4:30 p.m. ET.

Another SEC filing revealed insider selling under a pre-established plan. Meta’s Jennifer Newstead submitted a Form 144 on Jan. 13 for a proposed sale of 519 Class A shares valued at roughly $332,679. The filing confirmed these shares would be sold pursuant to a Rule 10b5-1 trading plan, letting executives schedule trades ahead of time.

The immediate issue for traders is whether Reality Labs’ cuts are a one-time cleanup or the beginning of a broader pullback. If demand for wearables slows or VR expenses remain sticky, Meta might just shift savings from one bucket to ramp up AI investments, leaving total costs elevated.

Jan. 28 is the next major date to watch. Investors will be focused on any changes to capex plans, the speed of AI infrastructure expansion, and whether management signals more restructuring in Reality Labs alongside updates on the core ad business.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Rocket Lab stock just hit a record close — what’s driving RKLB now
Previous Story

Rocket Lab stock just hit a record close — what’s driving RKLB now

Kohl’s stock slides 5% as Jefferies trims target to $22, tariff ruling keeps retailers on edge
Next Story

Kohl’s stock slides 5% as Jefferies trims target to $22, tariff ruling keeps retailers on edge

Go toTop